Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
Clinical trial NCT06087653 · RECRUITING
Trial details
- NCT number
- NCT06087653
- Sponsor
- Starton Therapeutics, Inc
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-02
- Primary completion
- 2026-05-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.